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Dengue fever is a serious concern for Japanese people staying in Southeast Asia. In order to implement necessary
prophylactic measures for dengue fever in this population, we investigated the characteristics of dengue fever
among Japanese nationals living in Manila, Philippines. From 2012 to 2015, 175 Japanese expatriates were
diagnosed with dengue fever at the medical clinic of the Japanese Association Manila, Inc. Most of the patients
were employees of Japanese companies and their families and were long-term residents of Manila. Most patients
were either <10 years or in their 30s to 40s. Two patients (1.1 %) were diagnosed with dengue hemorrhagic fever.
No deaths due to dengue fever were reported. The reported number of patients with dengue fever has shown a
decreasing trend: from 55 cases in 2012 to 53 in 2013, 31 in 2014, and 36 in 2015. The results of this survey could
be useful for the development of effective dengue fever preventive measures such as health education and
provision of information among not only Japanese but also other foreigners residing in endemic areas.
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Dengue fever is of concern for Japanese people residing
in areas of Southeast Asia. Prevention of bites from in-
fected vector mosquitoes is strongly recommended to
prevent transmission of dengue fever in endemic areas.
From 2010 onward, the reported number of imported
dengue cases in Japan increased to more than 200 cases
per year, primarily due to outbreaks in Southeast Asian
countries [1–3]. Furthermore, in 2014, 162 autochthon-
ous dengue fever cases, probably originating from
imported cases, were reported in Tokyo and other areas
in Japan [3, 4].
Japanese law requires that all domestically diagnosed
dengue fever cases be reported to the Ministry of Health,
Labour and Welfare. However, the epidemiological
status of dengue fever in Japanese people residing in en-
demic regions remains unknown. In order to implement
appropriate prophylactic measures for dengue fever, such
as health education and provision of information, we* Correspondence: a-hamada@tokyo-med.ac.jp
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expatriates living in Manila, Philippines.Methods
Japanese individuals living in the Philippines who visited
the medical clinic of the Japanese Association Manila, Inc.,
run by the Japan Overseas Medical Fund, were recruited to
participate in this survey. This clinic is located in the busi-
ness area of Manila (Makati city), where many Japanese
companies are located. Approximately 10,000 Japanese ex-
patriates live in the Manila metropolitan area (information
from the Japanese Embassy in the Philippines), and the ma-
jority of them visit this clinic for their primary health care.
This clinic sees 9000–10,000 Japanese patients each year.
The clinic summarizes information regarding infectious
diseases among Japanese patients visiting this clinic each
month, which is reported to the Tokyo headquarters of the
Japan Overseas Medical Fund. These aggregated data
summarize the epidemiological status of dengue fever
(patient age, sex, and reason for staying in Manila) as well
as the seasonal onset of the disease. The reports describe
only the numbers of patients and disease conditions with-
out including individually identifiable patient information.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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the Japan Overseas Medical Fund and performed a retro-
spective survey by analyzing data from Japanese patients di-
agnosed with dengue fever between January 2012 and
December 2015.
Patients were tested for dengue fever using commercial
dengue nonstructural protein 1 (NS1) antigen (SD Bioline
Dengue NS1 Ag: Standard Diagnostics, Inc.), dengue-
specific IgM antibody (SD Bioline Dengue IgG/IgM:
Standard Diagnostics, Inc.), and dengue-specific IgA anti-
body (Assure Dengue IgA Rapid Test: MP Biomedicals)
assays [5]. Patients were diagnosed with dengue fever
based on positive results in any one of examinations.
More specifically, NS1 antigen analysis is considered
the first-line test for clinical diagnosis of dengue
fever. Patients with negative NS1 findings were
further subjected to dengue-specific IgM or IgA anti-
body assays; they were considered positive for infec-
tion based on positive results in either of these tests.
Dengue hemorrhagic fever was diagnosed according
to standards established by the Ministry of Health,
Labour and Welfare in Japan [2].
This study was performed following review and approval
from the Ethics Board of Tokyo Medical University (No.
3080).Table 1 Number of Japanese dengue patients visiting the Japanese
Total
Number of patients 175
Sex
Male 105 (60.0 %)
Female 70
Age (years)
<10 23 (13.1 %)
10~19 12 (6.9 %)
20~29 12 (6.9 %)
30~39 52 (29.7 %)
40~49 42 (24.0 %)
50~59 22 (12.6 %)
≥60 12 (6.9 %)
Purpose for visit
Sent by the company 88 (50.3 %)
Family members of company employee 81 (46.3 %)
Other 6 (3.4 %)
Severity
Hemorrhagic fever 2 (1.1 %)
Hospitalized 49 (28.0 %)
Mortality 0Results
During the 4-year study period (January 2012 to December
2015), 175 Japanese patients were diagnosed with dengue
fever at the medical clinic of the Japanese Association
Manila, Inc. (Table 1). For making diagnosis in these pa-
tients, NS1 antigen, IgM antibody, and IgA antibody tests
were performed for 127, 24, and 24 patients, respectively.
Of these patients, 105 were male and 70 were female. Their
ages ranged from 1 to 80 years, but most patients were
aged <10 years or in their 30s and 40s. The major reason
for staying in Manila was prolonged dispatch by companies
(88 cases) and their families (81 cases).
Two patients (1.1 %), a woman in her 30s and a teenage
girl, were diagnosed with dengue hemorrhagic fever but
recovered after hospitalization. No deaths due to dengue
fever were reported. Among all patients, 49 (28.0 %) were
hospitalized, most of whom were children <10 years of
age (9 cases) or adults in their 30s (21 cases).
Almost equal numbers of dengue fever cases were re-
ported in 2012 (55 cases) and 2013 (53 cases), but the
numbers decreased somewhat in 2014 (31 cases) and 2015
(36 cases) (Table 1). The percentages of patients with den-
gue fever among all patients who visited the clinic have
also decreased since 2014, dropping from 0.56 % in 2012
to 0.50 % in 2013, 0.27 % in 2014, and 0.29 % in 2015.Association Manila, Inc., medical clinic (2012–2015)
Year
2012 2013 2014 2015
55 53 31 36
32 36 21 16
23 17 10 20
11 7 3 2
5 2 2 3
6 2 3 1
14 17 11 10
13 13 7 9
1 8 5 8
5 4 0 3
25 32 17 14
29 20 13 19
1 1 1 3
2 0 0 0
16 18 10 5
0 0 0 0
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during the rainy season (between June and August)
(Fig. 1). However, in 2014 and 2015, fewer cases were re-
ported in the rainy season in contrast to the increased
number of patients reported between October and
November.
Discussion
A survey of European international travelers indicated
that 1–3 % of the travelers contracted dengue virus in-
fections during a 1-month stay in tropical areas [6]. In
Japan, more than 200 patients with imported dengue
fever have been reported annually since 2010 [3]. These
results suggest that international travelers visiting trop-
ical areas are at high risk for dengue fever; however, to
our knowledge, no investigations have reported the rates
of dengue fever among Japanese expatriates living in en-
demic areas. In the present report, we investigated the
status of dengue fever among Japanese people living in
Manila, Philippines.
In the current study, a total of 175 Japanese people
were diagnosed with dengue fever at the medical clinic
of the Japanese Association Manila, Inc., between 2012
and 2015. Most of the dengue patients were company
employees sent from Japan, as well as their families.
Sixty percent of the patients were male, and many were
<10 years or in their 30s and 40s. A survey of imported
dengue fever cases in Japan (n = 762, 2011–2014)
showed that about 60 % of patients were male, similar to
the percentage observed in the present survey; however,
a large proportion of the patients were in their 20s, in
contrast to the results of the present survey [3]. In the
present investigation, two (1.1 %) of the 175 cases were
diagnosed with dengue hemorrhagic fever, a lower inci-
dence rate than the 5 % reported in the abovementioned
study on imported dengue cases.
There have been several surveys on dengue fever
among expatriates. In an Israeli survey of long-term
travelers (mean duration of stay, 5.3 months), the ratioFig. 1 Monthly number of Japanese dengue patients visiting the
Japanese Association Manila, Inc., medical clinicof dengue fever seroconversion was 6.7 % [7]. A New
Zealand survey of long-term development aid workers in
Southeast Asia (mean duration of stay, 22 months) re-
ported a dengue fever seroconversion rate of 15.1 % [8].
Although we were unable to obtain the incidence rate in
our present study because the size of the population was
unknown, the results of this study and others indicate
that dengue fever is an infectious disease that affects ex-
patriates in endemic areas at a high frequency.
In the present study, the annual numbers of dengue
cases decreased from more than 50 in 2012 and 2013 to
30 to 40 in 2014 and 2015. The reported incidence of den-
gue fever has decreased considerably in the Philippines
since 2010, to just over 100,000 patients diagnosed annu-
ally [9, 10]. However, the Regional Office for the Western
Pacific of the World Health Organization summarized the
recent trend of dengue incidence in the Philippines [11],
reporting a rapid increase in the numbers of patients in
2012 and 2013, to approximately 180,000 and 170,000
cases, respectively. These numbers decreased to approxi-
mately 110,000 in 2014 but increased again to 160,000 in
2015 [11]. In the present survey, the dengue incidence rate
among Japanese people in Manila was lower in 2014,
probably because of the ameliorated epidemiological sta-
tus nationwide. Also, since 2012, we have offered periodic
educational lectures focused on dengue prevention for
Japanese people living in Manila. These awareness activ-
ities might have contributed to the implementation of
proactive preventive measures among Japanese people,
resulting in a consistently low incidence in 2015.
This retrospective study was based on data available from
monthly reports provided to the Japan Overseas Medical
Fund by the medical clinic of the Japanese Association
Manila, Inc. Therefore, we were able to access only limited
patient data such as age, sex, and reasons for staying in
Manila. In order to obtain more information about the epi-
demiological status of dengue fever among Japanese people
in Manila, future prospective surveys are required. To re-
veal the relevant factors associated with the decreased
prevalence of dengue patients since 2014, a questionnaire
survey may be effective to assess changes in preventive
measures against dengue fever among Japanese people.
Conclusions
The present study reports the status of dengue fever
among Japanese expatriates in Manila, Philippines. The
findings of this study may be useful for the development
of more effective preventive measures such as health
education and provision of information for dengue fever
among not only Japanese people but also other
foreigners living in endemic areas.
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